QUICKLINKS AND VIEW OPITONS
Merck lied about heart attacks with its anti-inflammatory drug, Vioxx (rofecoxib), Peter Gotzsche MD
Saturday, February 07, 2015 10:53 am Email this article
Merck lied about heart attacks with it’s drug, Vioxx [ rofecoxib, a non-steroidal anti-inflammatory drug, a Cox-2 inhibitor ] which is estimated to have killed about 30,000 people notes Prof. Peter Gotzsche, MD in this video clip.
Merck was told by the FDA to tell American doctors, but instead, they told doctors that the risk of heart attack with it’s drug was one-eighth (1/8) that of other drugs notes Prof. Peter Gotzsche, MD.
“There was the VIGOR trial.
[ VIOXX Gastrointestinal Outcomes Research Trial ].”
“Where was it published?
In the New England Journal of Medicine which is the favorite journal by drug companies.”
“Three (3) cases of myocardial infarction [ heart attacks ] had been deleted [ from the published study. ]”
“Almost one million [ 1,000,000 ] reprints was [sic] bought by Merck.”
“So this journal [ the New England Journal of Medicine ] has a HUGE conflict of interest.”
At the beginning of his speech, Prof. Peter Gøetsche, MD says,
“What the drug industry publishes, even in the New England Journal of Medicine, should be viewed as an ADVERTISEMENT and nothing else.”
Prof. Peter Gotzsche, MD cofounded the Cochrane Collaboration in 1993.
It is a non-profit organization of scientists around the world who analyze data to try and figure out the truth about drugs and other health topics.
Prof. Peter Gotzsche, MD is the author of “Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare”
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.